Price target upside
MiNK Therapeutics, Inc. Price Target: +246.1% vs Current Price
INKT target gap is +246.1% from $11.27 to $39.00. As of 2026-08-16.
Direct answer
MiNK Therapeutics, Inc.'s analyst target implies +246.1%.
The average target is $39.00 compared with a recorded current price of $11.27.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 16, 2026.
Get free MiNK Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.27
- Average price target
- $39.00
- High price target
- $43.00
- Low price target
- $35.00
- Low target gap
- +210.6%
- Target upside
- +246.1%
- High target gap
- +281.5%
- Target range width
- 71%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- August 16, 2026
- Valid through
- August 23, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does MiNK Therapeutics, Inc.'s average target imply?
MiNK Therapeutics, Inc.'s average target is $39.00 versus a recorded price of $11.27. The difference is +246.1%.
How far are MiNK Therapeutics, Inc.'s low and high targets from the recorded price?
The low target implies +210.6%, while the high target implies +281.5%.
How many analysts are included in MiNK Therapeutics, Inc.'s consensus?
The verified consensus includes 2 analysts.
How is MiNK Therapeutics, Inc.'s target upside or downside calculated?
The average target of $39.00 is divided by the recorded price of $11.27, then one is subtracted to produce +246.1%. This does not guarantee a future return.
When was MiNK Therapeutics, Inc.'s analyst forecast verified?
The data was verified on 2026-08-16. The dataset is valid through 2026-08-23.